• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Disease and Therapy Review: Multiple Sclerosis Product Image

Disease and Therapy Review: Multiple Sclerosis

  • Published: November 2012
  • Region: Global
  • 15 Pages
  • Timely Data Resources, Inc

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities.

Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

The Multiple Sclerosis Disease and Therapy Review provides and overview of the disease and its types, global patterns READ MORE >

I. OVERVIEW

General description of the condition
Types of multiple sclerosis

II. INCIDENCE AND PREVALENCE

Risk factors
Incidence Table (US, Denmark, France, Italy, Spain, UK, Taiwan, Africa, Americas, Eastern Mediterranean, Europe, Western Pacific, Worldwide)
Prevalence Table (Canada, US, Denmark, England and Wales, France, Germany, Italy, Spain, UK, China, India, Japan, Taiwan, Africa, Americas, Eastern Mediterranean, Europe, South-East Asia, Western Pacific, Worldwide)

III. TREATMENT

Disease modifying agents
Steroids

IV. DOSING AND TREATMENT COSTS

Dosing for commonly prescribed drugs
Costs for commonly prescribed non-generic drugs

V. MARKET SIZE

Market overview
Sales information for key pharmaceuticals
Pipeline

VI. COMMENTS

VII. REFERENCES/RESOURCES

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos